A salamander that can regrow a severed leg has just handed scientists their clearest molecular clue yet about how the trick works. In a study published in Nature, researchers mapped how cells in a regenerating axolotl limb retain a kind of built-in GPS, a positional memory that tells new tissue whether to become an upper arm, a forearm, or a hand. At the center of that memory system sits a gene called Shox, already known in humans for its role in determining height. The overlap is striking: the same gene that helps decide how tall a child grows may also hold instructions for rebuilding lost anatomy.
The finding, reported by a team that included developmental biologists at Harvard and collaborating institutions, arrived in early 2025 and has continued to generate discussion into spring 2026. It marks a shift in regenerative medicine from asking whether positional information exists in regrowing limbs to identifying the specific genes that encode it.
A Molecular Map of Regrowth
The Nature paper used lineage tracing and targeted gene perturbations to follow individual cells through the regeneration process. After amputation, axolotl cells form a structure called a blastema, a mound of progenitor cells that serves as the construction site for the new limb. The researchers showed that cells within the blastema carry molecular coordinates dictating their future identity along the limb’s length. When they disrupted Shox, that coordinate system broke down, and the regenerating tissue lost its spatial organization.
Because Shox is conserved in humans and already linked to skeletal development, the connection between salamander regeneration and human biology is not a loose analogy. It is a shared piece of genetic architecture.
Supporting work has filled in more of the picture. A study in npj Regenerative Medicine examined axolotl digit regeneration and confirmed that hedgehog signaling, a molecular pathway active during human embryonic limb formation, is critical for patterning regrown digits. A separate multi-omics comparison published in Nature Communications identified shared gene expression programs across species during appendage regeneration, including wound epidermis formation and immune cell recruitment to injury sites. Together, these studies show that the molecular toolkit axolotls deploy is not unique to salamanders. Pieces of it exist in mammals, dormant but potentially reachable.
Early Signs in Mice
One experiment has already tested whether regeneration-linked genes can be switched on in a mammal. Researchers working with mouse models used an adeno-associated virus vector carrying FGF8, a growth factor gene, paired with a zebrafish-derived regeneration enhancer element to deliver the gene to amputated digit tips. The result, published in a peer-reviewed study indexed on PubMed Central, was a partial rescue of digit regrowth, not full restoration, but measurable improvement over untreated controls.
That outcome matters because it demonstrates a principle: mammalian cells are not permanently locked out of regeneration. With the right gene, delivered to the right cells at the right time, some regrowth can be coaxed back to life. A single-cell atlas integrating axolotl limb data with human and mouse datasets has since mapped where gene networks like FGF8 and Shox overlap across species, giving researchers a comparative scaffold for designing the next round of experiments.
The Distance Still to Travel
None of this means a human limb regrowth therapy is around the corner. The gap between partially rescuing a mouse digit tip and rebuilding a human arm spans orders of biological complexity. No published study has activated Shox or related positional memory genes in human cells to produce blastema-like structures. Expert commentary published alongside the Nature paper cautioned against overreading the results, noting that while the roles of Sonic hedgehog and spatial patterning genes are now better understood, adult mammals lost much of their regenerative capacity over evolutionary time. Reactivating one or two genes may not be enough to reconstruct the full cellular environment that regeneration demands.
Practical hurdles compound the biological ones. The research received support from the U.S. National Science Foundation, but no published grant abstracts outline budgets or timelines for moving Shox-based or hedgehog signaling interventions into primate or human trials. The path from a well-characterized gene in a salamander to a therapy for the roughly 2 million Americans living with limb loss, and tens of millions more worldwide, could require decades of additional work.
Why the Field Feels Different Now
What separates this moment from earlier waves of regeneration optimism is specificity. Previous research established that axolotls could regrow limbs and that certain cell populations were involved, but the molecular logic governing where and what to build remained opaque. The Shox discovery converts that mystery into a testable engineering problem. Scientists now have named molecular targets, conserved pathways confirmed across multiple species, and early proof that gene delivery tools can partially reactivate regrowth in mammals.
The strongest evidence in the current body of work comes from primary experimental data: the Nature paper’s molecular tracing of positional memory, the npj Regenerative Medicine study’s mechanistic detail on hedgehog signaling, and cross-species genomic comparisons identifying conserved regeneration programs. These are peer-reviewed results with quantitative backing, not conference abstracts or preprints. Foundational imaging work on axolotl digit regeneration established the baseline cell-type dynamics that these newer studies build on, clarifying which connective tissue progenitor populations must respond for true regeneration rather than simple wound closure.
The next critical experiments will test whether combining multiple gene activations, rather than flipping a single switch, can push mammalian cells past wound healing and into genuine regrowth. Those results, likely still years away, will determine whether the axolotl’s remarkable biology can deliver on its most ambitious promise: giving people back what injury and disease have taken.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
